HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fetal growth after laser therapy for twin-twin transfusion syndrome.

AbstractOBJECTIVE:
The objective of the study was to compare twin weight discordance and prevalence of intrauterine growth restriction (IUGR) before laser therapy and after birth in pregnancies complicated by twin-twin transfusion syndrome (TTTS).
STUDY DESIGN:
Women with TTTS who underwent laser therapy with dual neonatal survivors born at least 28 days after surgery were studied. Estimated fetal weight (EFW) discordance at the preoperative sonogram and birthweight (BW) discordance were calculated. Weights below gestational age-corrected 10th percentile at sonogram and at birth for each twin were designated as IUGR.
RESULTS:
Among 211 women studied, the mean EFW discordance measured 26.6% and mean BW discordance was 18.4%, yielding a mean 8.2% decrease in weight discordance (P < .001). Comparing IUGR diagnoses before surgery and at birth, the recipient's proportion was unchanged (9.5% vs 7.1%, P = .353), whereas the donor's proportion decreased (64.5% vs 28.9%, P < .001).
CONCLUSION:
Twin weight discordance and donor fetus IUGR appear to improve after laser therapy for TTTS.
AuthorsRamen H Chmait, Lisa M Korst, Patricia W Bornick, Mary H Allen, Rubén A Quintero
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 199 Issue 1 Pg. 47.e1-6 (Jul 2008) ISSN: 1097-6868 [Electronic] United States
PMID18295741 (Publication Type: Comparative Study, Journal Article, Twin Study)
Topics
  • Adult
  • Birth Weight
  • Female
  • Fetal Development
  • Fetal Growth Retardation (epidemiology)
  • Fetal Weight
  • Fetofetal Transfusion (surgery)
  • Gestational Age
  • Humans
  • Laser Therapy
  • Pregnancy
  • Pregnancy Outcome
  • Prevalence
  • Ultrasonography, Prenatal

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: